Stoke Therapeutics Inc (STOK)

Stoke Therapeutics Inc (STOK) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.7B; returns 1 day -2.6%, 1 week +3.6%, 1 year -21.0%.

Stoke Therapeutics Inc. is a biotechnology company focused on developing RNA-based medicines to address the underlying causes of severe genetic diseases by upregulating protein expression.

Groups STOK belongs to

• Biotechnology
• Life Sciences
• Rare Diseases
• CNS Disorders
• Clinical Stage Biotech
• Epilepsy
• Clinical Stage
• Healthcare
• Biopharmaceutical
• Neurological Disorders
• Neuroscience

STOK financial model: income statement, cash flow and balance sheet